DE602004004875D1 - Verwendung von Galectin-2 - Google Patents

Verwendung von Galectin-2

Info

Publication number
DE602004004875D1
DE602004004875D1 DE602004004875T DE602004004875T DE602004004875D1 DE 602004004875 D1 DE602004004875 D1 DE 602004004875D1 DE 602004004875 T DE602004004875 T DE 602004004875T DE 602004004875 T DE602004004875 T DE 602004004875T DE 602004004875 D1 DE602004004875 D1 DE 602004004875D1
Authority
DE
Germany
Prior art keywords
galectin
nucleic acid
complementary strand
coding
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004004875T
Other languages
English (en)
Other versions
DE602004004875T2 (de
Inventor
Axel Dignass
Stefan Rosewicz
Andreas Sturm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Charite Universitaetsmedizin Berlin
Original Assignee
Charite Universitaetsmedizin Berlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Charite Universitaetsmedizin Berlin filed Critical Charite Universitaetsmedizin Berlin
Publication of DE602004004875D1 publication Critical patent/DE602004004875D1/de
Application granted granted Critical
Publication of DE602004004875T2 publication Critical patent/DE602004004875T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
DE602004004875T 2004-03-26 2004-03-26 Verwendung von Galectin-2 Expired - Fee Related DE602004004875T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04007345A EP1593386B1 (de) 2004-03-26 2004-03-26 Verwendung von Galectin-2

Publications (2)

Publication Number Publication Date
DE602004004875D1 true DE602004004875D1 (de) 2007-04-05
DE602004004875T2 DE602004004875T2 (de) 2007-10-31

Family

ID=34924535

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004004875T Expired - Fee Related DE602004004875T2 (de) 2004-03-26 2004-03-26 Verwendung von Galectin-2

Country Status (4)

Country Link
EP (1) EP1593386B1 (de)
AT (1) ATE354369T1 (de)
DE (1) DE602004004875T2 (de)
ES (1) ES2282750T3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1908476A1 (de) * 2006-09-28 2008-04-09 Charite-Universitätsmedizin Berlin Galectin-2 zur Behandlung von Hautentzündungskrankheiten
WO2009140722A1 (en) * 2008-05-19 2009-11-26 The University Of Queensland A modified galectin-2 and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002322082A (ja) * 2001-04-26 2002-11-08 Purotejiin:Kk 腎炎の予防・治療剤
US20040023855A1 (en) * 2002-04-08 2004-02-05 John Constance M. Biologic modulations with nanoparticles

Also Published As

Publication number Publication date
ES2282750T3 (es) 2007-10-16
EP1593386A1 (de) 2005-11-09
EP1593386B1 (de) 2007-02-21
ATE354369T1 (de) 2007-03-15
DE602004004875T2 (de) 2007-10-31

Similar Documents

Publication Publication Date Title
CY1123050T1 (el) Φαρμακα ινδολιδονης για την θεραπεια ή προληψη ινωτικων ασθενειων
EP1601248A4 (de) Verwendung von nabelschnurblut zur behandlung von subjekten, die an einer krankheit, einem leiden oder einer störung leiden
ES2173812A1 (es) Dermis artificial y metodo de obtencion.
ATE402663T1 (de) Flächiges implantat
MXPA05008406A (es) Compuestos de amida tri(ciclo)-sustituida.
WO2006009765A3 (en) Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells
UY29777A1 (es) Utilización de agomelatina para la obtención de medicamentos destinados al tratamiento de trastornos del sueno en pacientes con depresión.
ATE547061T1 (de) Bogenelement für eine orthodonte spange
HK1106171A1 (en) Tetrahydropyridothiophenes
HK1130018A1 (en) Treatment of parkinson's disease or parkinsonian disorders using agents that decrease the activity of the melanocortin 4 receptor
EP1536834A4 (de) Entwurf von chemokin-analoga zur behandlung von erkrankungen des menschen
DK1526840T3 (da) Nanopartikler til DNA administration til et målorgan
PT1699480E (pt) AGENTE TERAPjUTICO ANTI-TUMORAL ALOGÉNICO
WO2006125815A3 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
MX2009010451A (es) Peptidos con capacidad para unirse a la interleuquina 10 (il-10).
ATE354369T1 (de) Verwendung von galectin-2
WO2003039591A3 (de) Allogene vakzine enthaltend eine ein costimulatorisches polypeptid exprimierende tumorzelle
IL203873A0 (en) Novel targets and compounds for therapeutic intervention of hiv infection
EP1130123A3 (de) Diagnosemethode
DK2175877T3 (da) Anvendelse af muterede antitrombiner til behandling eller forebyggelse af koagulationssygdomme
TW200628168A (en) Use of organic compounds
DE60326931D1 (de) In kanzerösen mammazellen differentiell exprimierte genprodukte und ihre verwendungsverfahren
DK1596879T3 (da) Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis
WO2002060476A3 (de) Tumorvakzine
AU2003227593A1 (en) New analogs of nitrobenzylthioinosine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee